Moreover, while pre-treatment with IFN protected cancer cells from VV infection, TSA was able to rescue virus infectivity, suggesting that the HDACI enhances VV replication in tumour cells mainly through inhibition of the IFN anti-viral response. This evidence concerns the gene IFNA1 and neoplasm.